Takeshi Tajima Selected Research

Takeshi Tajima Research Topics

Disease

7	Infections 03/2020 - 10/2007
6	Pneumonia (Pneumonitis) 05/2017 - 10/2004
5	Neoplasms (Cancer) 02/2021 - 07/2015
3	Disease Progression 02/2021 - 04/2006
2	Aplastic Anemia (Anemia, Hypoplastic) 04/2021 - 08/2019
2	Exanthema (Rash) 02/2021 - 10/2012
2	Communicable Diseases (Infectious Diseases) 02/2021 - 06/2013
2	Breast Neoplasms (Breast Cancer) 09/2020 - 01/2017
2	Otitis Media 09/2019 - 01/2018
1	Nausea 04/2021
1	Prostatic Neoplasms (Prostate Cancer) 09/2020
1	Carcinogenesis 09/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Esophageal Squamous Cell Carcinoma 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Fatigue 10/2016
1	Myalgia 10/2016
1	Thrombocytopenia (Thrombopenia) 02/2016
1	Multiple Myeloma 02/2016
1	Diarrhea 02/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2015
1	Chemical and Drug Induced Liver Injury 07/2015
1	Hypersensitivity (Allergy) 10/2014
1	Mycoplasma Pneumonia 12/2012
1	Epistaxis (Nosebleed) 10/2012
1	Stomatitis 10/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2012
1	Bacterial Infections (Bacterial Infection) 10/2007
1	Virus Diseases (Viral Diseases) 10/2007
1	Coinfection 10/2007
1	Pneumococcal Infections 10/2005

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 10/2004
4	MacrolidesIBA 01/2020 - 10/2005
4	Minocycline (Cyclops)FDA LinkGeneric 08/2017 - 12/2006
3	Conjugate VaccinesIBA 09/2019 - 10/2005
2	eltrombopag FDA Link 04/2021 - 08/2019
2	PanobinostatIBA 01/2018 - 02/2016
2	Doxycycline (Periostat)FDA LinkGeneric 08/2017 - 12/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2021
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2021
1	CreatinineIBA 04/2021
1	Alkaline PhosphataseIBA 02/2021
1	spartalizumabIBA 02/2021
1	Prolactin Receptors (Prolactin Receptor)IBA 09/2020
1	Thrombopoietin ReceptorsIBA 08/2019
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Cyclin DIBA 01/2018
1	ribociclibIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	TFXIBA 08/2017
1	tosufloxacinIBA 08/2017
1	L 084IBA 05/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	elgemtumabIBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	sonidegibIBA 10/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2016
1	Bortezomib (Velcade)FDA Link 02/2016
1	ceritinibIBA 07/2015
1	Anaplastic Lymphoma KinaseIBA 07/2015
1	Lipase (Acid Lipase)FDA Link 07/2015
1	Penicillins (Penicillin)FDA Link 10/2014
1	tebipenemIBA 06/2013
1	panipenemIBA 06/2013
1	Anti-Infective Agents (Microbicides)IBA 12/2012
1	Everolimus FDA Link 10/2012
1	Ampicillin (Omnipen)FDA LinkGeneric 10/2007
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2007
1	C-Reactive ProteinIBA 10/2007
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2007
1	Sulbactam FDA LinkGeneric 10/2007
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2007
1	Clindamycin (Cleocin)FDA LinkGeneric 12/2006
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 10/2005
1	16S Ribosomal RNAIBA 10/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2021 - 04/2006
3	Therapeutics 01/2018 - 07/2015
1	Stem Cell Transplantation 04/2021
1	Castration 09/2020
1	Ambulatory Care (Outpatient Care) 03/2020